MO2 - MODELLING OVERALL SURVIVAL IN IMMUNOTHERAPY USING PARAMETRIC TECHNIQUES- AVELUMAB IN PREVIOUSLY TREATED METASTATIC MERKEL CELL CARCINOMA
Abstract
Authors
A. Bullement A. Amin C. Stapelkamp A. Willis C. Lilley A.J. Hatswell C. Pescott M. Bharmal